Locating Regions of Interest in Generalized Anxiety Disorder Using Function Magnetic Resonance Imaging (fMRI) (fMRI)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01607710|
Recruitment Status : Completed
First Posted : May 30, 2012
Last Update Posted : September 5, 2014
|Condition or disease|
|Generalized Anxiety Disorder|
|Study Type :||Observational|
|Actual Enrollment :||55 participants|
|Official Title:||Locating Regions of Interest in Generalized Anxiety Disorder Using Function Magnetic Resonance Imaging (fMRI)|
|Study Start Date :||July 2012|
|Actual Primary Completion Date :||June 2014|
|Actual Study Completion Date :||June 2014|
Generalized Anxiety Disorder
The group of participants diagnosed with generalized anxiety disorder.
Nonclinical Control Group
The comparison group of participants with no psychiatric diagnoses.
- Brain activation while undergoing the fMRI [ Time Frame: Throughout the fMRI ]Main effects for each condition will be calculated to elucidate brain activations relevant to the tasks. Random effect 2 sample t-tests will assess group differences (i.e., GAD patients vs. healthy controls) to identify regions that demonstrate hyperactivation in patients.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01607710
|United States, Connecticut|
|Hartford, Connecticut, United States, 06105|
|Principal Investigator:||Gretchen J Diefenbach, Ph.D.||Hartford Hospital|